Literature DB >> 29485129

Prostate cancer: AR-Vs not predictive in mCRPC.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29485129     DOI： 10.1038/nrurol.2018.24

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

Review 1.  Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide.

Authors:  Gerhardt Attard; Emmanuel S Antonarakis
Journal:  Nat Rev Urol       Date:  2016-11-02       Impact factor: 14.432

2.  Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer.

Authors:  Sarah Q To; Edmond M Kwan; Heidi C Fettke; Andrew Mant; Maria M Docanto; Luciano Martelotto; Patricia Bukczynska; Nicole Ng; Lisa-Jane K Graham; Phillip Parente; Carmel Pezaro; Kate Mahon; Lisa Horvath; Tilman Todenhöfer; Arun A Azad
Journal:  Eur Urol       Date:  2018-06       Impact factor: 20.096
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.